Envestnet Asset Management
MLAB icon

Envestnet Asset Management’s Mesa Laboratories MLAB Stock Holding History

Envestnet Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Buy
8,816
+192
+2% +$19.3K ﹤0.01% 3706
2026
Q1 		$763K Buy
8,624
+1,692
+24% +$146K ﹤0.01% 3634
2025
Q4 		$544K Sell
6,932
-9,750
-58% -$742K ﹤0.01% 3649
2025
Q3 		$1.12M Sell
16,682
-3,801
-19% -$274K ﹤0.01% 3265
2025
Q2 		$1.93M Buy
20,483
+1,425
+7% +$156K ﹤0.01% 2848
2025
Q1 		$2.26M Buy
19,058
+1,463
+8% +$199K ﹤0.01% 2650
2024
Q4 		$2.32M Sell
17,595
-150
-0.8% -$18.4K ﹤0.01% 2598
2024
Q3 		$2.3M Sell
17,745
-1,722
-9% -$203K ﹤0.01% 2558
2024
Q2 		$1.69M Sell
19,467
-66
-0.3% -$6.91K ﹤0.01% 2696
2024
Q1 		$2.14M Buy
19,533
+6,216
+47% +$626K ﹤0.01% 2526
2023
Q4 		$1.4M Sell
13,317
-7,794
-37% -$760K ﹤0.01% 2693
2023
Q3 		$2.22M Buy
21,111
+8,001
+61% +$1.02M ﹤0.01% 2326
2023
Q2 		$1.68M Buy
13,110
+80
+0.6% +$12.2K ﹤0.01% 2382
2023
Q1 		$2.28M Buy
13,030
+433
+3% +$77.6K ﹤0.01% 2120
2022
Q4 		$2.09M Buy
12,597
+1,327
+12% +$208K ﹤0.01% 2132
2022
Q3 		$1.59M Sell
11,270
-1,520
-12% -$277K ﹤0.01% 2224
2022
Q2 		$2.61M Buy
12,790
+1,546
+14% +$338K ﹤0.01% 1927
2022
Q1 		$2.87M Buy
11,244
+1,495
+15% +$406K ﹤0.01% 1986
2021
Q4 		$3.2M Buy
9,749
+686
+8% +$215K ﹤0.01% 1863
2021
Q3 		$2.74M Buy
9,063
+518
+6% +$147K ﹤0.01% 1891
2021
Q2 		$2.32M Buy
8,545
+671
+9% +$170K ﹤0.01% 1956
2021
Q1 		$1.92M Buy
7,874
+2,165
+38% +$596K ﹤0.01% 1961
2020
Q4 		$1.64M Buy
5,709
+227
+4% +$62.5K ﹤0.01% 1883
2020
Q3 		$1.4M Buy
5,482
+403
+8% +$95.8K ﹤0.01% 1822
2020
Q2 		$1.1M Buy
5,079
+345
+7% +$79.5K ﹤0.01% 1911
2020
Q1 		$1.07M Buy
4,734
+907
+24% +$224K ﹤0.01% 1783
2019
Q4 		$954K Sell
3,827
-26
-0.7% -$6.09K ﹤0.01% 2057
2019
Q3 		$916K Buy
3,853
+550
+17% +$127K ﹤0.01% 2001
2019
Q2 		$807K Sell
3,303
-264
-7% -$61.5K ﹤0.01% 2090
2019
Q1 		$822K Buy
3,567
+103
+3% +$23.3K ﹤0.01% 2014
2018
Q4 		$722K Buy
+3,464
New +$676K ﹤0.01% 1932
2018
Q3 		– Sell
-2,248
Closed -$475K – 2064
2018
Q2 		$475K Buy
2,248
+197
+10% +$34.5K ﹤0.01% 1343
2018
Q1 		$304K Buy
2,051
+476
+30% +$64.9K ﹤0.01% 1403
2017
Q4 		$196K Sell
1,575
-263
-14% -$36.8K ﹤0.01% 1856
2017
Q3 		$274K Buy
1,838
+124
+7% +$17.5K ﹤0.01% 1704
2017
Q2 		$246K Sell
1,714
-84
-5% -$11.9K ﹤0.01% 1795
2017
Q1 		$221K Buy
1,798
+324
+22% +$39.7K ﹤0.01% 1879
2016
Q4 		$181K Buy
1,474
+260
+21% +$32.5K ﹤0.01% 1932
2016
Q3 		$139K Buy
1,214
+190
+19% +$21.7K ﹤0.01% 2189
2016
Q2 		$126K Sell
1,024
-277
-21% -$29.8K ﹤0.01% 2331
2016
Q1 		$125K Buy
+1,301
New +$117K ﹤0.01% 2296

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Envestnet Asset Management's MLAB Position: Q2 2026 in Review

Envestnet Asset Management increased its Mesa Laboratories (MLAB) stake by 2.2% in Q2 2026, buying an estimated $19.3K and bringing the position to 8,816 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #3706.

Envestnet Asset Management first reported a position in MLAB in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.2M in Q4 2021. 33 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Envestnet Asset Management held 8,816 shares of Mesa Laboratories worth $878K as of Q2 2026.
  • Envestnet Asset Management bought 192 Mesa Laboratories shares in Q2 2026, an estimated $19.3K.
  • Mesa Laboratories made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3706 holding.
  • Envestnet Asset Management first reported a position in Mesa Laboratories in Q1 2016 and has held it in 41 quarters since.
  • Envestnet Asset Management's Mesa Laboratories position peaked at $3.2M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.